Supported Projects

2018 Ukrainian National Call for Project

The planned study aims to clarify the role of the intestinal microbiota in the formation of fatty liver and atherogenesis in patients with a comorbid course of non-alcoholic fatty liver disease and coronary heart disease. The effect of combination treatment with an additional probiotic containing a strain Bifidobacterium infantis 35624 of 1 capsule per day for 4 weeks will be investigated in comparison with standard therapy regimens for the course of non-alcoholic fatty liver disease without clinical signs of coronary heart disease and in combination with them.